代孕 | 代孕 | 代孕 | 北京代孕 | 深圳代孕 | 武汉代孕 | 武汉代孕 | 上海代孕 | 武汉代孕 | 捐卵

Consensus estimates

Estimates for Q2 2017/18 and FY 2017/18

    Q2 16/17 Q2 17/18 FY 16/17 FY 17/18
DKKm   Actual Consensus Actual Consensus
           
Revenue   613 654 2.084 2.606
Gross profit   341 383 1.124 1.534
EBIT   121 140 356 557
Net profit   84 93 250 350
           
Growth, organic   15% 14% 9% 15%
Gross margin   55.6% 58.5% 53.9% 58.9%
EBIT margin   19.7% 21.4% 17.1% 21.4%
FCF   51 138 285 303
           
Endoscopes sold (units)   95,000 128,755 364,000 542,209

23 April 2018, based on estimates from 4 analysts. However, FCF for Q2 17/18 is only based on input from 1 analyst.

keyboard_arrow_up
代孕 | 代孕 | 代孕 | 北京代孕 | 深圳代孕 | 武汉代孕 | 武汉代孕 | 上海代孕 | 武汉代孕 | 捐卵